LILY34:BVMF
Eli Lilly And Company BDR
199,78Â R$
0,00%
(0,00) 1K
7-okt, 17:07:00 (GMT-3) · BRL
search
Barcha belgilar
| Belgi | Narxi | Oʻzgartirishlar | Dinamika (%) |
|---|
insights_autoLILY34 tikeri uchun statistika yaratilmoqda...
Ochish
194,10Â R$
Yuqori
200,82Â R$
Past
193,98Â R$
Bozor kapitali
1,12Â trln
Oʻrtacha hajm
36,37Â ming
Hajmi
48,91Â ming
52 haftalik eng yuqori
223,07Â R$
52 haftalik eng past
141,56Â R$
Muomaladagi aksiyalar
941,36Â mln
Xodimlar soni
50Â ming
Ochish
194,10Â R$
Yuqori
200,82Â R$
Past
193,98Â R$
Bozor kapitali
1,12Â trln
Oʻrtacha hajm
36,37Â ming
Hajmi
48,91Â ming
52 haftalik eng yuqori
223,07Â R$
52 haftalik eng past
141,56Â R$
Muomaladagi aksiyalar
941,36Â mln
Xodimlar soni
50Â ming
Yangiliklar
Internet manbalari va yangilik hamkorlarimizdan
Yahoo Finance
·
5 soat oldin
Moderna, Eli Lilly Lead Healthcare Stocks Higher on a Down Day for Markets
The Globe and Mail
·
6 soat oldin
Where Will Eli Lilly Stock Be in 5 Years? Follow the Pipeline Beyond Zepbound
Stock Titan
·
6 soat oldin
Eli Lilly (LLY) shareholder Lilly Endowment proposes another sale after $386M in August proceeds.
Traders Union
·
8 soat oldin
Why is Eli Lilly stock up 3.4% today?
Profil
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named.
The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so.
The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
Eli Lilly And Company BDR haqida
CEODavid A. Ricks
Xodimlar soni50Â ming
Asos solingan1876
Bosh ofislarIndianapolis, Indiana, Amerika Qo‘shma Shtatlari
Sektor-
Veb-saytlilly.com